Recent advances in the development of sphingosine kinase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent advances in the development of sphingosine kinase inhibitors

Published:2016-09 Issue:9 Volume:28 Page:1349-1363
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Pitman Melissa R.,Costabile Maurizio,Pitson Stuart M.

Funder

Fay Fuller Foundation

Royal Adelaide Hospital Research Fund Early Career Fellowship to MRP, and a Senior Research Fellowship

National Health and Medical Research Council of Australia

Publisher

Elsevier BV

Subject

Cell Biology

Reference159 articles.

1. Regulation of sphingosine kinase and sphingolipid signaling;Pitson;Trends Biochem. Sci.,2011

2. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature;Chun;Pharmacol. Rev.,2002

3. Sphingosine 1-phosphate is a ligand for peroxisome proliferator-activated receptor-gamma that regulates neoangiogenesis;Parham;FASEB J.,2015

4. Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond;Kunkel;Nat. Rev. Drug Discov.,2013

5. Sphingosine-1-phosphate signaling and its role in disease;Maceyka;Trends Cell Biol.,2012

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sphingosine kinase 1-specific inhibitor PF543 reduces goblet cell metaplasia of bronchial epithelium in an acute asthma model;American Journal of Physiology-Lung Cellular and Molecular Physiology;2024-03-01

2. The emerging roles of sphingosine 1-phosphate and SphK1 in cancer resistance: a promising therapeutic target;Cancer Cell International;2024-02-28

3. The shifting lipidomic landscape of blood monocytes and neutrophils during pneumonia;JCI Insight;2024-02-22

4. Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or Venetoclax;Pharmaceutics;2024-01-31

5. Investigating potential of cholic acid, syringic acid, and mangiferin as cancer therapeutics through sphingosine kinase 1 inhibition;International Journal of Biological Macromolecules;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3